Kaskela Law LLC announces that it is investigating Privia Health Group, Inc. (“Privia”) (NASDAQ: PRVA) on behalf of the company’s shareholders.

Since September 2022, shares of Privia’s common stock have declined in value from a trading price of over $41.00 per share to a current trading price of less than $30.00 per share, a cumulative decline of over 25% in value.

The investigation seeks to determine whether Privia and/or the company’s representatives violated the securities laws by issuing false and/or misleading statements, or by failing to disclose material information, to Privia shareholders, thereby causing investor losses.

Privia stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the information form on this page, for additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
[email protected]